Anton Neschadim, Ph.D.
Affiliations: | 2011 | Medical Biophysics | University of Toronto, Toronto, ON, Canada |
Area:
Molecular Biology, ImmunologyGoogle:
"Anton Neschadim"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Jeffrey A. Medin | grad student | 2011 | University of Toronto | |
| (Development of Novel Cell Fate Control Gene Therapy for Applications in Cancer and Immune Disorders.) | ||||
Children
Sign in to add trainee| Tian Sun | research scientist | 2019- | ImmunoBiochem Corporation (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Neschadim A, Medin JA. (2019) Engineered Thymidine-Active Deoxycytidine Kinase for Bystander Killing of Malignant Cells. Methods in Molecular Biology (Clifton, N.J.). 1895: 149-163 |
| Resetca D, Neschadim A, Medin JA. (2016) Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns. Journal of Immunotherapy (Hagerstown, Md. : 1997) |
| Neschadim A, Kotra LP, Branch DR. (2016) Small molecule phagocytosis inhibitors for immune cytopenias. Autoimmunity Reviews |
| Sato T, Neschadim A, Nakagawa R, et al. (2015) Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis. Methods in Molecular Biology (Clifton, N.J.). 1317: 55-67 |
| Neschadim A, Summerlee AJ, Silvertown JD. (2015) Targeting the relaxin hormonal pathway in prostate cancer. International Journal of Cancer. 137: 2287-95 |
| Leontyev D, Neschadim A, Branch DR. (2014) Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain. Transfusion. 54: 2871-9 |
| Neschadim A, Pritzker LB, Pritzker KP, et al. (2014) Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts. Endocrine-Related Cancer. 21: 459-71 |
| Purohit MK, Chakka SK, Scovell I, et al. (2014) Structure-activity relationships of pyrazole derivatives as potential therapeutics for immune thrombocytopenias. Bioorganic & Medicinal Chemistry. 22: 2739-52 |
| Sato T, Neschadim A, Lavie A, et al. (2013) The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer. Plos One. 8: e78711 |
| Purohit MK, Scovell I, Neschadim A, et al. (2013) Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cells. Bioorganic & Medicinal Chemistry Letters. 23: 2324-7 |